IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 149 filers reported holding IMPAX LABORATORIES INC in Q2 2013. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $460,245,000 | -29.8% | 23,663 | -39.9% | 0.00% | 0.0% |
Q4 2017 | $655,777,000 | -17.7% | 39,386 | +0.4% | 0.00% | -50.0% |
Q3 2017 | $796,430,000 | +110.5% | 39,233 | +67.0% | 0.00% | +100.0% |
Q2 2017 | $378,318,000 | +99.0% | 23,498 | +56.4% | 0.00% | 0.0% |
Q1 2017 | $190,117,000 | +6.8% | 15,029 | +11.8% | 0.00% | 0.0% |
Q4 2016 | $178,093,000 | -33.7% | 13,441 | +18.5% | 0.00% | 0.0% |
Q3 2016 | $268,805,000 | -72.7% | 11,342 | -66.8% | 0.00% | -75.0% |
Q2 2016 | $985,875,000 | +32.5% | 34,208 | +47.2% | 0.00% | +33.3% |
Q1 2016 | $744,145,000 | +27.3% | 23,240 | +69.9% | 0.00% | +200.0% |
Q4 2015 | $584,786,000 | +12.1% | 13,676 | -7.7% | 0.00% | 0.0% |
Q3 2015 | $521,531,000 | +90.4% | 14,812 | +148.3% | 0.00% | 0.0% |
Q2 2015 | $273,913,000 | +8.4% | 5,965 | +10.6% | 0.00% | 0.0% |
Q1 2015 | $252,723,000 | +449.0% | 5,392 | +271.1% | 0.00% | – |
Q4 2014 | $46,031,000 | -78.9% | 1,453 | -84.2% | 0.00% | – |
Q3 2014 | $218,488,000 | +68.0% | 9,215 | +112.5% | 0.00% | – |
Q2 2014 | $130,067,000 | +54.8% | 4,337 | +34.9% | 0.00% | – |
Q1 2014 | $84,046,000 | +276.9% | 3,214 | +262.3% | 0.00% | – |
Q4 2013 | $22,299,000 | -94.2% | 887 | -95.2% | 0.00% | – |
Q3 2013 | $381,847,000 | -20.6% | 18,654 | -22.6% | 0.00% | – |
Q2 2013 | $480,875,000 | – | 24,104 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |